|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 13/12 | (2006.01) | ||
| A61K 38/02 | (2006.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 13/00 | (2006.01) | ||
| C07K 16/40 | (2006.01) |
| (11) | Number of the document | 2465534 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10183893.6 |
| Date of filing the European patent application | 2005-06-09 | |
| (97) | Date of publication of the European application | 2012-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-29 |
| (46) | Date of publication of the claims translation | 2017-07-25 |
| (30) | Number | Date | Country code |
| 578847 P | 2004-06-10 | US |
| (72) |
Schwaeble, Hans-Wilhelm, GB
Stover, Cordula M., GB
Tedford, Clark E., US
Parent, James B., US
Fujita, Teizo, JP
|
| (73) |
Omeros Corporation,
201 Elliott Avenue West, Seattle, WA 98119,
US
University Of Leicester, University Road, Leicester Leicestershire LE1 7RH, GB |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ligų, susijusių su nuo MASP-2 priklausomu komplemento aktyvavimu, gydymo būdai |
| Methods for treating conditions associated with MASP-2 dependent complement activation |
| Payment date | Validity (years) | Amount | |
| 2024-05-20 | 347.00 EUR |